3Gladman J .Pharmacists paid to improve drug compliance, persistency[J] .Payment Strategies Pharm Care,1997, 10: 4.
4Bond WS,Hussar DA .Detection methods and strategies for improving medication compliance [J ] .Am J Hosp Pharm , 1991,48: 1 978.
5Rudd P .Maximizing compliance with antihypertensive therapy [J ] . Drug Therap, 1992, 22: 25.
6United Kingdom Prospective Diabetes Study Group. Tight bloom pressure control and risk of macrovascular and microvascular complications in type 2 diabetes(UKPD:38) [J]. BMJ,1998, 317(7160):703-713.
7Bittar N. Maintaining long-term control of blood pressure: the role improved compliance. Clin Cardiol, 1995, 18 suppl Ⅲ: Ⅲ12-Ⅲ16.
8Payne KA, Esmonde-White S. Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence? Curr Hypertens Rep, 2000, 2:515-524.
9Cohen JS. Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians' Desk Reference. Arch Intern Med, 2001, 161:880-885.
